Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06268574
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-01-05
Brief Title:
Safety and Efficacy of RVU120 for Treatment of RelapsedRefractory AML
Sponsor:
Ryvu Therapeutics SA
Organization:
Ryvu Therapeutics SA
Organization Data
Organization:
Ryvu Therapeutics SA
Class:
INDUSTRY
Study ID:
RIVER-52
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ryvu Therapeutics SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None